在急性-慢性肝衰竭 (ACLF) 设置中进行心肝联合移植
Deepali Dahale1, Aditya Kunte2, Sandeep Sinha3
1Critical Care-Liver Transplant, Department of GI & Hepatobiliary Sciences, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, India.
Indian journal of thoracic and cardiovascular surgery
|February 12, 2026
概括
本案例报告详细介绍了第一个针对急性至慢性肝衰竭 (ACLF) 的心脏和肝脏联合移植 (CHLT) 病例. 成功的程序突显了CHLT在复杂的双器官故障场景中的可行性.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
背景情况:
- 结合心脏和肝脏移植 (CHLT) 是同时发生双器官衰竭的罕见手术.
- 这位患者出现了缺血性心肌病,严重的充血性心力衰竭和二次急性至慢性肝衰竭 (ACLF).
- 以前的治疗方法,包括最大限度的医疗治疗和自动植入式心脏转换器-除器 (AICD) 植入不够.
研究的目的:
- 报告第一个针对ACLF二次至高级心力衰竭进行的CHLT病例.
- 描述这样一个病例的复杂的外科手术和术后管理.
- 为了证明CHLT在这个具有挑战性的临床环境中的可行性和结果.
主要方法:
- 一名58岁的男性患有末期心脏和肝功能衰竭,同时接受了 ортотоп CHLT.
- 该程序涉及从双心室辅助装置 (BiVAD) 过渡到心肺旁路 (CPB) 进行器官植入.
- 术后管理包括解决诸如感染,毒性和危急疾病肌肉病变等并发症.
主要成果:
- 患者在复杂的CHLT手术中幸存下来,移植后3个月就出院了.
- 移植后5个月,患者表现出正常的双心脏和肝功能,没有排斥迹象.
- 成功管理了手术后并发症,包括细胞巨乳病毒 (CMV) 感染和多药耐药性败血症.
结论:
- 对于二次至高级心力衰竭的ACLF患者来说,CHLT是一种可行的治疗选择.
- 多学科的方法对于管理与CHLT相关的复杂的外科手术挑战至关重要.
- 这一案例强调了在罕见而复杂的双器官移植场景中取得成功结果的潜力.
更多相关视频
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
11.1K
16:19Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
13.2K
相关概念视频
Liver Histology
4.5K
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Hepatocytes perform a variety of essential functions. They secrete...
4.5K
Liver Physiology
3.8K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.8K
Liver Regeneration
4.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.4K
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V
515
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
